Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report
Dr. Tyndale is investigating genetic risk factors for drug dependence to better understand the mechanisms involved with drug abuse and to optimize treatment approaches. Drugs under study include ethanol, opiates, benzodiazepines and amphetamines with a focus on nicotine and smoking. She is tackling the serious public health issue of smoking and trying to find answers to the questions why some people smoke more than others, and why some find it easier to quit. Dr. Tyndale’s goal is to use genetic information to personalize treatment for people who want to quit smoking. The techniques range from molecular identification and characterization of novel genetic polymorphisms to in vivo pharmacokinetic, abuse liability, epidemiological, and treatment studies. Another area of her research involves the study of the unique regulation, function, and toxicity of cytochrome P450 enzymes in the central nervous system. Dr. Tyndale is assessing how commonly used drugs such as nicotine or ethanol regulate these enzymes and the subsequent impact on treatment drugs, as well as drugs of abuse. The techniques range from western blotting and mRNA approaches, to in vitro and in vivo drug metabolism, to behavioural/toxicity studies.
DSM-IV, ICD-10 and FTND: Discordant Tobacco Dependence Diagnoses in Adult Smokers
Jill C Mwenifumbo and Rachel F Tyndale*
Research Article: J Addict Res Ther 2011, 2:105
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals